Pudong New Area

Broker's Calls

Only time will tell if Singapore’s healthcare players can expand successfully

SINGAPORE (April 20): OCBC Investment Research is remaining “neutral” on Singapore’s healthcare sector on the observation that China remains an attractive choice for growth among local private healthcare companies despite challenges abound.
×